Measurement and significance of circulating natriuretic peptides in cardiovascular disease

Clinical Science

Volumn 95, Issue 5, 1998, Pages 519-529

  Sagnella, G A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cardiovascular disease; Heart failure; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

AMINO TERMINAL SEQUENCE; AORTA STENOSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIASTOLE; EXTRACELLULAR SPACE; HEART ATRIUM PRESSURE; HEART DILATATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VALVE STENOSIS; HEART VENTRICLE FUNCTION; HUMAN; HYPERTENSION; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MASS SCREENING; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; TACHYCARDIA;

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RISK FACTORS;

EID: 0031772642     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0950519     Document Type: Review

References (95)

1. Sagnella, G. A. and MacGregor, G. A. (1990) Atrial natriuretic peptides. Quart. J. Med. 77, 1001-1007
2. Blaine, E. H. (1990) Atrial natriuretic factor plays a significant role in body fluid homeostasis. Hypertension 15, 2-8
3. John, S. W. M., Krege, J. H., Oliver, P. M. et al. (1995) Genetic decrease in atrial natriuretic peptide and salt-sensitive hypertension. Science (Washington DC) 267, 679-681
4. Lopez, M. J., Wong, S. K., Kishimoto, I. et al. (1995) Salt resistant hypertension in mice lacking the guanylate cyclase-A receptor for atrial natriuretic peptide. Nature (London) 378, 65-68
5. Holmes, S. J., Espiner, E. A., Richards, A. M., Yandle, T. G. and Frampton, C. (1993) Renal, endocrine and haemodynamic effects of human brain natriuretic peptide in normal man. J. Clin. Endocrinol. Metab. 76, 91-96
6. Lang, C. C., Choy, A. J. and Struthers, A. D. (1992) Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis. Clin. Sci. 83, 519-527
7. Yoshimura, M., Hirofumi, Y., Morita, E. et al. (1991) Haemodynamic, renal and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 84, 1581-1588
8. Wilkins, M. R., Unwin, R. J. and Kenny, A. J. (1993) Endopeptidase 24.11 and its inhibitors: potential therapeutic agents for edematous disorders and hypertension. Kidney Int. 43, 273-285
9. Mcdonagh, T. A., Morrison, C. E., Lawrence, A. et al. (1997) Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350, 829-833
10. Barnett, D. B. (1993) Heart failure. Diagnosis of symptomless left ventricular dysfunction. Lancet 341, 1124-1125
11. De Marco, T. and Goldman, L. (1997) Predicting outcomes in severe heart failure. Circulation 95, 2597-2599
12. Poole, S., Rose, E., Das, G., Dzau, V. J., Richards, A. M. and Robertson, J. I. S. (1988) The International Standard for Atrial Natriuretic Factor: Calibration by an International Collaborative Study. Hypertension 6, 629-634
13. Richards, A. M., Tonolo, G., McIntyre, G. D., Leckie, B. J. and Robertson, J. I. (1987) Radio-immunoassay for plasma alpha human atrial natriuretic peptides: comparison of direct and pre-extracted methods. J. Hypertens. 5, 227-236
14. Richards, A. M. (1987) Human plasma atrial natriuretic peptide concentrations in health and disease. Curr. Opin. Cardiol. 2, 660-670
15. Buckley, M. G., Sagnella, G. A. and MacGregor, G. A. (1987) Plasma acidification increases atrial natriuretic peptide as measured by radioimmunoassay. Clin. Chem. 33, 1104-1105
16. Thibault, G., Garcia, R., Gutkowska, J. et al. (1987) The propeptide Asn1-Tyr126 is the storage form of rat atrial natriuretic factor. Biochem. J. 241, 265-272
17. Yandle, T., Crozier, I., Nicholls, G., Espiner, E., Carne, A. and Brennan, S. (1987) Amino acid sequence of atrial natriuretic peptides in human coronary sinus plasma. Biochem. Biophys. Res. Commun. 146, 832-839
18. Ando, K., Hirata, Y., Emori, T. et al. (1990) Circulating forms of human atrial natriuretic peptide in patients with congestive heart failure. J. Clin. Endocrinol. Metab. 70, 1603-1607
19. Miyata, A., Toshimori, T., Hashiguchi, T., Kangawa, K. and Matsuo, H. (1987) Molecular forms of atrial natriuretic polypeptides circulating human plasma. Biochem. Biophys. Res. Commun. 142, 461-467
20. Meleagros, L., Ghatei, M. A., Gibbs, J. S. R. and Bloom, S. R. (1989) Pro-atrial natriuretic peptide (1-98): the circulating cardiodilatin in man. Peptides 10, 545-550
21. Buckley, M. G., Sagnella, G. A., Markandu, N. D., Singer, D. R. J. and MacGregor, G. A. (1990) Concentrations of N-terminal Pro ANP in human plasma: evidence for proANP (1-98) as the circulating form. Clin. Chim. Acta 191, 1-14
22. Azizi, C., Maistre, G., Kalotka, H. et al. (1996) Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure. J. Endocrinol. 148, 51-57
23. Nakao, K., Ogawa, Y., Suga, S. and Imura, H. (1992) Molecular biology and biochemistry of the natriuretic peptide system: natriuretic peptides. J. Hypertens. 10, 907-912
24. Mukoyama, M., Nakao, K., Hosoda, K. et al. (1991) Brain natriuretic peptide as a novel cardiac hormone in humans. J. Clin. Invest. 87, 1402-1412
25. Yasue, H., Yoshimura, M., Sumida, H. et al. (1994) Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90, 195-203
26. Lang, C. C., Choy, A. M., Turner, K., Tobin, R., Coutie, W. and Struthers, A. D. (1993) The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in man. J. Hypertens. 11, 737-741
27. Yandle, T. G., Richards, A. M., Gilbert, A., Fisher, S., Holmes, S. and Espiner, E. A. (1993) Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J. Clin. Endocrinol. Metab. 76, 832-838
28. Lang, C. C., Coutie, W. J., Khong, T. K., Choy, A. M. J. and Struthers, A. D. (1991) Dietary sodium loading increases plasma brain natriuretic peptide levels in man. J. Hypertens. 9, 779-882
29. Buckley, M. G., Markandu, N. D., Sagnella, G. A. and MacGregor, G. A. (1994) Brain and atrial natriuretic peptides: a dual peptide system of potential importance in sodium balance and blood pressure regulation in patients with essential hypertension. J. Hypertens. 12, 809-813
30. Tateyama, H., Hino, J., Minamino, N. et al. (1992) Concentrations and molecular forms of human brain natriuretic peptide in plasma. Biochem. Biophys. Res. Commun. 185, 760-767
31. Togashi, T., Fujita, S., Kurosawa, T., Hasegawa, N., Kikawada, R. and Kawakami, M. (1993) Circulating forms of B-type natriuretic peptide after acute myocardial infarction. Clin. Chem. 39, 550-551
32. Ruskoaho, H. (1992) Atrial natriuretic peptide: synthesis, release and metabolism. Pharmacol. Rev. 44, 479-602
33. Nakao, K., Ogawa, Y., Suga, S. and Imura, H. (1992) Molecular biology and biochemistry of the natriuretic peptide system II: natriuretic peptide receptors. J. Hypertens. 10, 1111-1114
34. Buckley, M. G., Markandu, N. D., Miller, M. A., Sagnella, G. A. and MacGregor, G. A. (1993) Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J. Human Hypertens. 7, 245-250
35. Kohno, M., Horio, T., Yokokawa, K. et al. (1992) Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am. J. Med. 92, 29-34
36. Nishikimi, T., Yoshihara, F., Morimoto, A. et al. (1996) Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28, 22-30
37. Crozier, I. G., Ikram, H., Nicholls, M. G., Espiner, E. A. and Yandle, T. G. (1987) Atrial natriuretic peptide in spontaneous tachycardias. Br. Heart J. 58, 96-100
38. Kohno, M., Horior, T., Toda, I. et al. (1992) Cosecretion of atrial and brain natriuretic peptidcs during supraventricular tachyarrhythmias. Am. Heart J. 123, 1382-1384
39. Richards, A. M., Cleland, J. G. F., Tonolo, G. et al. (1986) Plasma atrial natriuretic peptide in cardiac impairment. Br. Med. J. 293, 409-412
40. Burnett, Jr., J. C., Kao, P. C., Hu, D. C. et al. (1986) Atrial natriuretic peptide elevation in congestive heart failure in the human. Science (Washington DC) 231, 1145-1147
41. Anderson, J. V., Woodruff, P. W. and Bloom, S. R. (1988) The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. Br. Heart J. 59, 207-211
42. Jensen, K. T., Carstens, J., Ivarsen, P. and Pedersen, E. B. (1997) A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand. J. Clin. Lab. Invest. 57, 529-540
43. Lang, C. C., Prasad, N., McAlpine, H. et al. (1994) Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am. Heart J. 127, 1635-1636
44. Matsumoto, A., Hirata, Y., Momomura, S. et al. (1995) Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am. Heart J. 129, 139-145
45. Ikeda, T., Matsuda, K., Itoh, H. et al. (1997) Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am. Heart J. 133, 307-314
46. Hasegawa, K., Fujiwara, H., Doyama, K. et al. (1993) Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 88, 372-380
47. Morita, E., Yasue, H., Yoshimura, M. et al. (1993) Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88, 82-91
48. Buckley, M. G., Sethi, D., Markandu, N. D., Sagnella, G. A., Singer, D. R. J. and MacGregor, G. A. (1992) Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin. Sci. 83, 437-444
49. Lang, C. C., Choy, A. M. J., Henderson, I. S., Coutie, W. J. and Struthers, A. D. (1992) Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure. Clin. Sci. 82, 127-131
50. Feldschuh, J. (1990) Blood volume measurements in hypertensive disease. In Hypertension, Pathophysiology, Diagnosis and Treatment (Laragh, J. H. and Brenner, B. M., eds.), pp. 339-347, Raven Press, New York
51. London, G. M., Safar, M. E., Safar, A. L. and Simon, A. C. (1985) Blood pressure in the 'low-pressure system' and cardiac performance in essential hypertension. J. Hypertens. 3, 337-342
52. Yoshimura, M., Yasue, H., Okumura, K. et al. (1993) Different secretion patterns of atrial natriuretic peptide in patients with congestive heart failure. Circulation 87, 464-469
53. Rodeheffer, R. J., Naruse, M., Atkinson, J. B. et al. (1993) Molecular forms of atrial natriuretic factor in normal and failing human myocardium. Circulation 88, 364-371
54. Fischer, T. A., Haass, M., Dietz, R. et al. (1991) Transcription, storage and release of atrial natriuretic factor in the failing human heart. Clin. Sci. 80, 285-291
55. Saito, Y., Nakao, K., Arai, H. et al. (1989) Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J. Clin. Invest. 83, 298-305
56. Hosada, K., Nakao, K., Mukoyama, M. et al. (1991) Expression of brain natriuretic gene in human heart. Production in the ventricle. Hypertension 17, 1152-1155
57. Mukoyama, M., Nakao, K., Saito, Y. et al. (1990) Increased human brain natriuretic peptide in congestive heart failure. N. Engl. J. Med. 323, 757-758
58. Arad, M., Elazar, E., Shotan, A., Klein, R. and Rabinowitz, B. (1996) Brain natriuretic and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure. Cardiology 87, 12-17
59. Wei, C. M., Heublein, D. M., Perrella, M. A. et al. (1993) Natriuretic peptide system in heart failure. Circulation 88, 1004-1009
60. Hunt, P. J., Richards, A. M., Nicholls, M. G., Yandle, T. G., Doughty, R. N. and Espiner, E. A. (1997) Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin. Endocrinol. 47, 287-296
61. McKenzie, J. C., Kelley, K. B., Merisko-Liversidge, E. M., Kennedy, J. and Klein, R. M. (1994) Developmental pattern of ventricular atrial natriuretic peptide (ANP) expression in chronically hypoxic rats as an indicator of the hypertrophic process. J. Mol. Cell Cardiol. 26, 753-767
62. Hasegawa, K., Fujiwara, H., Doyama, K. et al. (1993) Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies. Am. J. Pathol. 142, 107-116
63. Tanaka, M., Hiroe, M., Nishikawa, T., Sato, T. and Marumo, F. (1994) Cellular localization and structural characterization of natriuretic peptide-expressing ventricular myocytes from patients with dilated cardiomyopathy. J. Histochem. Cytochem. 42, 1207-1214
64. Nishigaki, K., Tomita, M., Kagawa, K. et al. (1996) Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy. J. Am. Coll. Cardiol. 28, 1234-1242
65. Takemura, G., Fujiwara, H., Mukoyama, M. et al. (1991) Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation 83, 181-190
66. de Bold, A. J., Bruneau, B. G. and de Bold, M. L. K. (1996) Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc. Res. 31, 7-18
67. Haug, C., Metzele, A., Kochs, M., Hombach, V. and Grunert, A. (1993) Plasma brain natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure. Clin. Cardiol. 16, 553-557
68. Yamada, Y., Goto, J. and Yokoto, M. (1997) Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease. Cardiology 88, 401-407
69. Yamamoto, K., Burnet, Jr., J. C., Jougasaki, M. et al. (1996) Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28, 988-994
70. Davidson, N. C., Naas, A. A., Hanson, J. K., Kennedy, N. S., Coutie, W. J. and Struthers, A. D. (1996) Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am. J. Cardiol. 77, 828-831
71. Yu, C. M., Sanderson, J. E., Shum, I. O. L. et al. (1996) Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with restrictive filling pattern. Eur. Heart J. 17, 1694-1702
72. Francis, G. S., Benedict, C., Johnston, D. E. et al. (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 82, 1724-1729
73. Winters, C. J., Sallman, A. L., Baker, B. J., Meadows, J., Rico, D. M. and Vesely, D. L. (1989) The N-terminus and a 4000-MW peptide from the mid portion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure. Circulation 80, 438-449
74. Lerman, A., Gibbons, R., Rodeheffer, R. J. et al. (1993) Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 341, 1105-1109
75. Choy, A. M., Darbar, D., Lang, C. C. et al. (1994) Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic and neurohormonal methods. Br. Heart J. 72, 16-22
76. Omland, T., Aakvaag, A. and Vik-Mo, H. (1996) Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 76, 232-237
77. Muders, F., Kromer, E. P., Griese, D. P. et al. (1997) Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am. Heart J. 134, 442-449
78. Cowie, M. C., Struthers, A. D., Wood, D. A. et al. (1997) Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350, 1347-1351
79. McDonagh, T. A., Robb, S. D., Murdoch, D. R. et al. (1998) Biochemical detection of left-ventricular systolic dysfunction. Lancet 351, 9-13
80. Arakawa, N., Nakamura, M., Aoki, H. and Hiramori, K. (1994) Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology 85, 334-340
81. Naruse, M., Takeyama, Y., Tanabe, A. et al. (1994) Atrial and brain natriuretic peptides in cardiovascular diseases. Hypertension 23, 1231-1234
82. Horio, T., Shimada, K., Kohno, M. et al. (1993) Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am. Heart J. 126, 293-299
83. Weisman, H. F. and Healey, B. (1987) Myocardial infarct expansion, infarct expansion and reinfarction: pathophysiologic concepts. Prog. Cardiovasc. Dis. 30, 73-110
84. Gottlieb, S. S., Kukin, M. L., Ahern, D. and Packer, M. (1989) Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J. Am. Coll. Cardiol. 13, 1534-1539
85. Wallen, T., Landahal, S., Hedner, T. et al. (1997) Atrial natriuretic peptides predict mortality in the elderly. J. Int. Med. 241, 269-275
86. Omland, T., Bonarjee, V. V., Nilsen, D. W. et al. (1993) Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation. Br. Heart J. 70, 409-414
87. Hall, C., Rouleau, J. L., Moye, L. et al. (1994) N-Terminal proatrial natriuretic factor - an independent predictor of long term prognosis after myocardial infarction. Circulation 89, 1934-1942
88. Darbar, D., Davidson, N. C., Gillespie, N. et al. (1996) Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am. J. Cardiol. 78, 284-287
89. Omland, T., Aakvaag, A., Bonarjee, V. V. et al. (1996) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93, 1963-1969
90. Tsutamoto, T., Wada, A., Maedo, K. et al. (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96, 509-516
91. Davis, M., Espiner, E., Richards, G. et al. (1994) Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 343, 440-444
92. Lang, C. C., Coutie, W. J., Struthers, A. D., Dhillon, D. P., Winter, J. H. and Lipworth, B. J. (1992) Elevated levels of brain natriuretic peptides in acute hypoxaemic chronic obstructive pulmonary disease. Clin. Sci. 83, 529-533
93. Lervasi, C. A., Del Chicca, M. G., Maffei, S. et al. (1996) Analytical performance and clinical usefulness of a commercially available IRMA kit for measuring atrial natriuretic peptide in patients with heart failure. Clin. Chem. 42, 1627-1633
94. Smith, R. F., Johnson, G., Ziesche, S. et al. (1993) Functional capacity in heart failure. Comparison of methods for assessment and their relation to other indexes of heart failure. Circulation 87 (Suppl. VI), VI-88-VI-93
95. Murdoch, D. R., Byrne, J., Morton, J. J. et al. (1997) Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart 78, 594-597